#USA #FDA Approval #Wuhan #Rhein Laser #UroFiber 60Q

Rhein Laser Expands Horizons with FDA Approval for UroFiber 60Q

Rhein Laser Technologies Co., a pioneer in medical laser innovations, proudly announces that its UroFiber® 60Q SuperPulsed Thulium Fiber Laser System has officially received FDA 510(k) clearance as of November 19, 2024. This achievement marks a significant milestone not just for the company but also for the field of urology, showcasing advancements in surgical laser technology.

What sets the UroFiber 60Q apart from its counterparts is its superior performance metrics. With a laser output that boasts a 20% higher peak power and a 15% greater average output, this device has redefined standards in laser technology within the medical arena. During laser lithotripsy procedures, this enhanced output allows for a notably faster fragmentation of kidney stones, resulting in reduced treatment time and minimized collateral tissue damage. This efficiency is linked directly to improved recovery times for patients, offering them a quicker path to healing.

For soft tissue treatments, the UroFiber 60Q’s precision laser capabilities significantly decrease instances of bleeding and thermal injury to surrounding tissues. By shortening the recovery period and enhancing patient outcomes, this groundbreaking system holds the potential to transform current approaches to urological surgery and patient care.

Obtaining FDA 510(k) approval not only affirms that the UroFiber 60Q meets rigorous safety and efficacy standards but also opens up new market opportunities for Rhein Laser on both American and international fronts. As the first Chinese enterprise to secure FDA clearance for a thulium fiber laser technology, Rhein Laser is poised to introduce its cutting-edge solutions to a broader audience while driving advancements in medical technology globally.

Looking ahead, the company is already progressing with the upcoming UroFiber 150Q, another sophisticated system that promises to elevate the standard in laser treatment. This model features a unique pulse energy of 10J and is designed with a 200um application fiber, allowing it to operate at a frequency of 15Hz with a peak output power of 150W. These specifications will position the UroFiber 150Q as an unparalleled player in urological laser therapy, promising faster and more effective treatment options.

Dr. Lin Yang, CEO of Rhein Laser, emphasized the company’s commitment to innovation, stating, "With our robust R&D teams based in Düsseldorf and Wuhan, we blend German precision with Chinese innovation efficiency, pushing the boundaries of laser technology. Our mission is to deliver world-class medical laser solutions that significantly improve patient outcomes across the globe."

As a testament to its dedication to excellence, the UroFiber 60Q is set to become a pivotal asset in the evolution of laser-assisted urological treatments. With its FDA certification and advanced technology, it promises enhanced safety, precision, and overall patient care, which could potentially reshape medical practices worldwide.

To learn more about the UroFiber laser system, visit www.UroFiber.com for further information and details.

Contact: [email protected]